Join Gilead-Kite surfing into the future of cell therapy. Listen to Nordic researchers discuss perspectives and future promise of CAR-T in haemato-oncology and solid tumours, CAR-T, TCR, CAR-NK, allo-CAR development and the exciting future of immuno-oncology to combat cancer.
Host: Mike Barnkob, MD. PhD. Odense University Hospital, Denmark. 

Latest Episodes

Ep. 07: Use of T cell receptors (TCR’s) as immunotherapy against cancer

In this episode we interview Dr. Johanna Olweus and Dr. Morten Milek Nielsen from University of Oslo about the use of T cell receptors (TCR’s) as immunotherapy against...

Ep. 06: CRISPR and its use in cellular therapies

In this episode we talk to Dr. Rasmus O Bak from Aarhus University about the use of CRISPR and its use in cellular therapies. CRISPR has now become a method to not onl...

Ep. 05: NK cells as anti-cancer medicine. Interview with Dr Arnika K. Wagner, Dr Evren Alici and Dr Sigrid Skånland

What are NK cells, how do they function and how can we utilize them as a cellular therapy? In this episode we are joined by Dr Arnika K. Wagner and Dr Evren Alici, bot...

Ep. 04: What is precision medicine? Interview with Dr Caroline Heckman and Dr Kjetil Tasken

What is precision medicine? How can cancer patients benefit from it, and what role does it play in cellular therapy? In this episode our guests Dr Caroline Heckman (Re...

Ep.03 Chimeric antigen receptors

Chimeric antigen receptor therapy has revolutionized hematology but is there ways we could further improve the immune cells that delivery the therapy? In this episod...

More Episodes »
Broadcast by